In the world of fierce competition, patent expirations, shrinking margins, and fast-changing models, pharmaceutical and life science companies are restructuring their business models to provide their customers with value-based services and drugs. Organizations in pharmaceutical and life sciences need to invest in new age tools and technologies to share their value proposition with patients, providers, payers, and regulatory bodies. Healthcare industry experiences and a strong portfolio of up-coming generation solutions and services must empower organizations to propel innovation across various business initiatives along with optimization of clinical trials, digital health, patient engagement, evidence from the real world, health outcomes, and others.
In the early stages of technological innovations, regulatory changes, and increased emphasis on patient-centered models, life sciences companies appear to have multiple growth opportunities. Life sciences indeed remain one of the industries that is ahead of them seeing rapid technological evolution. Although life sciences have been considered a sluggish technology adopter over the years, the industry's future looks better—with companies embracing new technologies for age-old patient care. Not only that, today's life sciences companies are digitalizing their routine tasks with a vision of investing their time in innovating and creating new, more progressive and patient-centered business models.
A distinguished panel of CIOs, CEOs, CTOs, analysts, and the CIO Applications editorial board evaluated numerous life science technology vendors and shortlisted the outstanding ones to help companies seeking competent solutions in the field of life sciences. In addition to recording customer satisfaction, the companies have been identified based on the quality of their solutions and services. In this edition of CIO Applications, we present you the "Top 25 Life Sciences Technology Vendors – 2018".
